Infections in splenectomized patient;Infections chez le patient splénectomisé

Revue du Praticien

Volumn 58, Issue 20, 2008, Pages 2209-2214

  Coignard Biehler, Hélène ^a   Lanternier, Fanny ^a   De Montalembert, Mariane ^b   Mahlaoui, Nizar ^c   Suarez, Felipe ^d   Lecuit, Marc ^a   Lortholary, Olivier ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Centre d'Infectiologie Necker Pasteur   (France)

^c Service de Pediatrie Generale   (France)

^d Centre D'Étude des Déficits Immunitaires   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIBODY CONJUGATE; CEFTRIAXONE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MENINGOCOCCUS VACCINE; PENICILLIN DERIVATIVE; PENICILLIN V; PLACEBO; POLYSACCHARIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; CHILD; DRUG DOSE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNIZATION; INCIDENCE; INFLUENZA; LIVER DISEASE; NEISSERIA MENINGITIDIS; NONHUMAN; PATIENT EDUCATION; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; REVIEW; RISK REDUCTION; SPLENECTOMY; STAPHYLOCOCCAL PNEUMONIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; PATIENT EDUCATION AS TOPIC; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SPLEEN; SPLENECTOMY; TIME FACTORS; VACCINATION;

EID: 58549092049     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Chanet V, Lesens O, Laurichesse H, Beytout J. Infections chez l'adulte asplénique et prévention. Med Mal Infect 2004;34:493-8.
2. Kyaw MH, Holmes EM, Toolis F, et al. Evaluation of severe infection and survival after splenectomy. Am J Med 2006;119:276.e1-7.
3. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991;78:1031-8.
4. th edition. Mandell GL, Bennet JE, Dolin R (eds). Philadelphia: Churchill Livingstone, 2006.
5. Shaw JH, Print CG. Postsplenectomy sepsis. Br J Surg 1989;76:1074-81.
6. Gardembas-Pain M, Mege M, Pabot da Chatelard P. L'asplénisme du patient hodgkinien. Presse Med 2003;32:S10-1.
7. Bisharat H, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect 2001;43:182-6.
8. King H, Shumacker HB Jr. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg 1952;136:239-42.
9. Brigden ML. Detection, education and management of the asplenic or hyposplenic patient. Am Fam Physician 2001;63:499-508.
10. Sumaraju V, Smith LG, Smith SM. Infectious complications in asplenic hosts. Infect Dis Clin North Am 2001;15:551-65.
11. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working party of the british committee for standards in haematology clinical haematology task force. BMJ 1996;312:430-4.
12. Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 2001;54:214-8.
13. Landgren O, Björkholm M, Konradsen HB, et al. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. J Intern Med 2004;255:664-73.
14. Stoehr GA, Rose MA, Eber SW, Heidenann K, Schubert R, Zielen S. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis. Br J Haematol 2006;132:788-90.
15. Musher DM, Ceasar H, Kojic EM, et al. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis 2005;191:1063-7.
16. Eber SW, Langendörfer CM, Ditzig M, et al. Frequency of very late fatal sepsis after splenectomy for hereditary spherocytosis: impact of insufficient antibody response to pneumococcal infection. Ann Hematol 1999;78:524-8.
17. Chambon JP, Vallet B, Caiazzo R, Zerbib P. Prise en charge des patients splénectomisés. Presse Med 2003;32:S20-3.
18. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:1593-9.
19. Newland A, Provan D, Myint S. Preventing severe infection after splenectomy. BMJ 2005;331:417-8.
20. Davies JM, Baraes R, Milligan D. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med 2002;2:440-3.
21. de Montalembert M. Antibioprophylaxie des infections bactériennes chez l'enfant hyposplénique ou asplénique. Presse Med 2003;32:S15-6.
22. Julianov A, Palijska S, Nedkov N. Infection with unexpected microorganisms in splenectomised patients. Lancet 2002;360:949-50.
23. Lipman HM. Preventing severe infection after splenectomy: risk of malaria and meningitis increases with asplenia. BMJ 2005;331:576.
24. Keenan RD, Boswell T, Milligan DW. Do post-splenectomy patients take prophylactic penicillin? Br J Haematol 1999;105:509-10.
25. Corbett SM, Rebuck JA, Rogers FB, et al. Time lapse and comorbidities influence patient knowledge and pursuit of medical care after traumatic splenectomy. J Trauma 2007;62:397-403.
26. Katz SC, Pachter HL. Indications for splenectomy. Am Surg 2006;72:565-80.